A promising new treatment for COVID-19 infection
A promising new treatment for COVID-19 infection
Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure - PubMed
Thymoquinone: "notable antiviral activity against a SARSCoV-2 strain isolated from Egyptian patients..."studies also show TQ could "inhibit COVID-19 development through binding to receptor-binding domain on the spike and envelope proteins of SARS-CoV-2,"
Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure
potentially beneficial roles of thymoquinone... antioxidant, anti-inflammatory, immunomodulatory, epigenetic modulation, antiviral activity, docking studies on anti-COVID-19 activity, antibacterial & anticoagulant effects for the treatment of COVID-19."
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial - PubMed
Nigella Sativa supplementation "associated with faster recovery of symptoms than usual care alone for patients with mild COVID-19 infection. These potential therapeutic benefits require further exploration with placebo-controlled, double-blinded studies."
Prophetic Medicine-Nigella Sativa (Black cumin seeds) – Potential herb for COVID-19?
Prophetic Medicine-Nigella Sativa (Black cumin seeds) – Potential herb for COVID-19?
Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial
Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial
Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19
Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial - PubMed
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial